Show notes
Why Ozempic Doesn’t Work for Everyone: The DNA Clue
This episode explains why Ozempic and similar weight-loss drugs don’t work the same for everyone, highlighting a Stanford University study published in April 2026. Researchers found that about 10% of people carry variants in a single gene affecting the enzyme PAM, which helps activate the body’s natural GLP-1 hormone—the system these medications rely on. With a sluggish PAM “switch,” GLP-1 may not be properly activated, which could help explain why some patients lose a lot of weight while others see minimal results. The host offers three…
Website: listen.hubhopper.com

